Table 2.
Clinical characteristics of the critically ill patients and complication in ICU.
| Characteristic | COVID-19 group (n=9) | Non-COVID-19 group (n=12) | p |
|---|---|---|---|
| Age, mean (SD), year | 71.7 (8.1) | 68.9(20.2) | 0.706 |
| Sex ratio (F:M) | 8:1 | 8:4 | 0.338 |
| APACHE II, mean (SD) | 25.4(2.3) | 24.3(2.6) | 0.330 |
| Coexisting conditions, no. | |||
| Cardiovascular disease | 1/9 | 2/12 | 1 |
| Endocrine disease | 1/9 | 1/12 | 1 |
| Treatment in ICU | |||
| Glucocorticoid(in 7 day) | 3/9 | 0/12 | 0.063 |
| Etomidate | 0/9 | 0/12 | >0.05 |
| Azole antifungals | 3/9 | 0/12 | 0.063 |
| Complication in ICU | |||
| Bile acid (umol/l), median (IQR) | 5.96 (4.10-9.75) | 4.2 (1.82-10.35) | 0.345 |
| Use of vasopressors | 8/9 | 12/12 | 0.429 |
| Use of ventilator | 8/9 | 12/12 | 0.429 |
| Use of V-A ECMO | 7/9 | 0/12 | 0.000 |